Aisling Capital Management LP Portfolio Holdings

Aisling Capital Management LP

  • $273 Million
  • Q4 2024

Aisling Capital Management LP has filed its 13F form on February 12, 2025 for Q4 2024 where it was disclosed a total value porftolio of $273 Million distributed in 15 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Bridge Bio Pharma, Inc. with a value of $167M, Verona Pharma PLC with a value of $51.8M, Syndax Pharmaceuticals Inc with a value of $13.6M, Monte Rosa Therapeutics, Inc. with a value of $10.2M, and Poseida Therapeutics, Inc. with a value of $10M.

Examining the 13F form we can see an increase of $29.9M in the current position value, from $243M to 273M.

Aisling Capital Management LP is based out at New York, NY

Below you can find more details about Aisling Capital Management LP portfolio as well as his latest detailed transactions.

Portfolio value $273 Million
Healthcare: $273 Million

Stock Holdings Table Market Cap. of $10 Billions to $200 Billions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 15
  • Current Value $273 Million
  • Prior Value $243 Million
  • Filing
  • Period Q4 2024
  • Filing Date February 12, 2025
  • Form Type 13F-HR
  • Activity in Q4 2024
  • New Purchases 1 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Aisling Capital Management LP Portfolio

Follow Aisling Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aisling Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Aisling Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email